Asia-Pacific Lyophilized Injectable Drugs Market, By Packaging (Vials, Dual-Chamber Syringes, Dual-Chamber Cartridges and Others), Drug Class (Anti-Infectives, Antineoplastic, Diuretics, Proton Pump Inhibitor, Anesthetic, Anticoagulant, NSAID’s, Corticosteroids and Others), Form (Powder and Liquid), Indication (Oncology, Autoimmune Diseases, Hormonal Disorders, Respiratory Diseases, Gastrointestinal Disorders, Dermatological Disorders, Ophthalmic Diseases and Others), Route of Administration (Intravenous/Infusion, Intramuscular and Others), End User (Hospital, Clinics, Home Healthcare and Others), Distribution Channel (Direct Tender, Retail Sales and Others), Country (Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Rest of Asia-Pacific) Industry Trends and Forecast to 2028.
Get Exclusive Sample Copy of this Report Here
Market Analysis and Insights: Asia-Pacific Lyophilized Injectable Drugs Market
The lyophilized injectable drugs market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.7%, and is expected to reach USD 1,351.81 Million in the forecast period of 2021 to 2028. Large numbers of market players are involved in offering the lyophilized injectable drugs products with innovations that pave the way for the lyophilized injectable drugs market growth.
Lyophilization is a freeze-drying method for removing water from a finished product. The output products of lyophilization are frozen under high vacuum. In the biotechnological and pharmaceutical industries, the lyophilization process is used to create high-quality products with a longer shelf life.
Increase in chronic health conditions, increase in geriatric and overall population with cardiac and neurological defects, expansion of lyophilized injectable drug pipeline, reduced risk of administration of lyophilized injectable drugs with prefilled diluent syringes and technological advancement due to increased R&D are driving the Asia-Pacific lyophilized injectable drugs market.
Furthermore, lyophilization allows for safe transportation and storage of these substances until they are required. Injectable medications must now be lyophilized due to increased safety issues. After a long period of storage, lyophilized injectable drugs have proved to be safer and more convenient to administer than other dried items.
The lyophilized injectable drugs market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Get Exclusive Sample Copy of this Report Here
Asia-Pacific Lyophilized Injectable Drugs Market Scope and Market Size
The lyophilized injectable drugs market is categorized into seven notable segments which are based on the packaging, drug class, form, indication, route of administration, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of packaging, the lyophilized injectable drugs market is segmented into vials, dual-chamber syringes, dual-chamber cartridges and others. In 2021, vials segment is expected to dominate the lyophilized injectable drugs market because most of the lyophilized injectable drugs are packaged in vials, so it is influential as well as growing in the market.
- On the basis of drug class, the lyophilized injectable drugs market is segmented into anti-infective, antineoplastic, diuretics, proton pump inhibitor, anesthetic, anticoagulant, NSAID’s, corticosteroids and others. In 2021, anti-infective segment is expected to dominate the lyophilized injectable drugs market due to the high prevalence of chronic diseases in Asian region which is fostering the requirement for the antibiotics and antiviral drugs.
- On the basis of form, the lyophilized injectable drugs market is segmented into powder and liquid. In 2021, powder segment is expected to dominate the lyophilized injectable drugs market because it is highly used in storage plus transportation in Asia-Pacific region.
- On the basis of indication, the lyophilized injectable drugs market is segmented into oncology, autoimmune diseases, hormonal disorders, respiratory diseases, gastrointestinal disorders, dermatological disorders, ophthalmic diseases and others. In 2021, oncology segment is expected to dominate the lyophilized injectable drugs market as lyophilized injectable drugs are used in high used in oncology in the Asian region.
- On the basis of route of administration, the lyophilized injectable drugs market is segmented into intravenous/infusion, intramuscular and others. In 2021, intravenous/infusion segment is expected to dominate the lyophilized injectable drugs market due to the 100% bioavailability of the drug via this route of administration.
- On the basis of end user, the lyophilized injectable drugs market is segmented into hospital, clinics, home healthcare and others. In 2021, hospital segment is expected to dominate the lyophilized injectable drugs market because of the presence of skilled professionals in the Asian region.
- On the basis of distribution channel, the lyophilized injectable drugs market is segmented into direct tender, retail sales and others. In 2021, direct tender segment is expected to dominate the lyophilized injectable drugs market because the demand for direct tender is high in the Asia-Pacific region.
Lyophilized Injectable Drugs Market Country Level Analysis
The lyophilized injectable drugs market is analysed and market size information is provided by the country, packaging, drug class, form, indication, route of administration, end user and distribution channel as referenced above.
The countries covered in the Asia-Pacific lyophilized injectable drugs market Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, and Rest of Asia-Pacific.
China is expected to dominate the market due to rise in chronic health conditions and increase in geriatric population with chronic diseases.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
New Product Launches by Manufactures is Creating New Opportunities for Players in the Lyophilized Injectable Drugs Market
Lyophilized Injectable Drugs Market also provides you with detailed market analysis for every country growth in aesthetic industry with Lyophilized Injectable Drugs Market sales, impact of advancement in the lyophilized injectable drugs market and changes in regulatory scenarios with their support for the lyophilized injectable drugs market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Lyophilized Injectable Drugs Market Share Analysis
Lyophilized injectable drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to lyophilized injectable drugs market.
The major companies providing lyophilized injectable drugs in the Asia-Pacific lyophilized injectable drugs market are Affy Pharma Pvt Ltd., Genex Pharma, AuroMedics Pharma LLC Pharma LLC (a subsidiary of Aurobindo Pharma), Astellas Pharma US, Inc. (a subsidiary of Astellas Pharma Inc.), Aristopharma Ltd., Pfizer Inc., Sanofi, Celon Laboratories Pvt. Ltd. and Baxter among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many contracts and agreements are also initiated by the companies’ worldwide which are also accelerating the lyophilized injectable drugs market.
- In November 2019, Pfizer, Inc. announced that its division, named Upjohn is combined with Mylan N.V. and formed a new company named Viatris Inc. This combination of the company's business division with Mylan N.V. has increased its product portfolio, leading to increased demand for its product in the market.
Collaboration, joint ventures and other strategies by the market players is enhancing the company market in the lyophilized injectable drugs market which also provides the benefit for organisation to improve their offering for lyophilized injectable drugs market.
SKU-